TP53 and myelodysplastic syndrome: Furthermore, sequential whole-exome sequencing of two del(5q) patients at baseline and at AML transformation identified TP53 mutations in both patients at the time of leukemic transformation [but not in two non-del(5q) patients], suggesting that TP53 mutation is the critical event in progression of del(5q) MDS (19).